Form 4: DocuSign Director Sells $1.2M in Stock Under 10b5-1 Plan

DocuSign Director Peter Solvik sold 15,000 shares of common stock for over $1.2 million, executed under a Rule 10b5-1 plan.

Summary

• Peter Solvik, a Director of DocuSign, Inc. (DOCU), reported a transaction involving the sale of company common stock.
• On September 15, 2025, Solvik disposed of 15,000 shares of DocuSign common stock.
• The shares were sold at a price of $81.48 per share, totaling $1,222,200.
• This transaction was a direct disposition of securities and was made pursuant to a Rule 10b5-1 trading plan.
• Following this sale, Peter Solvik directly owns 6,783 shares of DocuSign common stock.
• Solvik also indirectly beneficially owns 207,272 shares through various entities: 65,558 shares via Children's Trusts, 6,458 shares via Spouse, 3 shares via a Family Partnership, and 135,253 shares via a Trust.

Sentiment

Score: 5

Explanation: A Form 4 filing detailing a pre-planned insider sale (Rule 10b5-1) is generally considered a routine event for liquidity or diversification purposes and does not inherently reflect positively or negatively on the company's immediate prospects.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This insider transaction is a routine disclosure for publicly traded companies, reflecting a director's personal financial planning rather than a direct commentary on broader industry trends or competitive positioning. Such sales are common for liquidity or diversification purposes.

Stakeholder Impact

• Shareholders: May interpret the sale as a director taking profits, but the Rule 10b5-1 plan mitigates concerns about it being based on new, undisclosed negative information. The overall impact is likely minimal.

Key Dates

Recommendation

A routine insider sale under a pre-arranged 10b5-1 plan does not typically indicate a change in company fundamentals or warrant a shift in investment thesis. It's a common liquidity event for executives, and this filing alone provides no new information to alter a fundamental investment decision.

Keywords

DocuSign, DOCU, Peter Solvik, Insider Sale, Form 4, 10b5-1 Plan, Director, Stock Transaction